Metabolic syndrome and life style factors among diabetes patients attending in a teaching hospital, Chitwan.
Journal
PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081
Informations de publication
Date de publication:
2023
2023
Historique:
received:
18
10
2022
accepted:
10
05
2023
medline:
29
5
2023
pubmed:
25
5
2023
entrez:
25
5
2023
Statut:
epublish
Résumé
Metabolic syndrome (MetS) is associated with an increased incidence of chronic complications and mortality of diabetes patients. Prevention and treatment of MetS is important means of lowering the risk of cardiovascular diseases and mortality. This study aimed to find out metabolic syndrome and life style factors among diabetes patients. A cross-sectional survey was carried out among 296 patients with type 2 diabetes mellitus attending Chitwan Medical College Teaching Hospital. Consecutive sampling technique was used to select sample. Data were collected from 15th December 2021 to 15th March, 2022 using Interview Schedule, bio-physiological measurement and record review. Obtained data were analysed in SPSS version 20 for window using descriptive and inferential statistics. Chi-square test was applied to measure the association between the variables. Logistic regression analysis was performed to identify the factors associated with metabolic syndrome. Findings revealed that the prevalence of MetS was 66.2% and 58.4% in patients according to International Diabetes Federation (IDF) and National Cholesterol Education Program Adult Treatment Panel III (NCEP ATP III) criteria respectively. The most common MetS parameters were raised fasting plasma glucose (94.6%) and abnormal waist circumference (78.4% in IDF criteria) while the least prevalent parameter was reduced HDL level (43.2%). Majorities of the patients were non-vegetarian (85.5%), had poor dietary compliance (poor-46.3%, very poor-32.1%), overweight/obese (65.5%), and suffered from moderate stress (90.1%). Bivariate analysis showed that MetS as per NCEP ATP criteria was significantly associated with gender (p = 0.006), occupation (p = 0.007), presence of other co-morbid condition (<0.001) and sleep problem (p = <0.001). However, MetS as per IDF criteria was significantly associated with age (p = <0.028), duration of diabetes (p = <0.001), follow-up visit (p = <0.030), blood sugar monitoring (p = <0.009) and physical activity of diabetes patients (p = <0.001). Further logistic regression analysis revealed that sleep problem (AOR = 21.812;95%CI = 8.512,55.894) and presence of other comorbidities (AOR = 4.024;95%CI = 2.220,7.295) were the significant factors of metabolic syndrome. Metabolic syndrome is high in patients with type 2 diabetes mellitus. Therefore, treating physicians and other health workers need to monitor MetS parameters regularly to reduce the risk of cardiovascular diseases, stroke and premature death.
Sections du résumé
BACKGROUND
Metabolic syndrome (MetS) is associated with an increased incidence of chronic complications and mortality of diabetes patients. Prevention and treatment of MetS is important means of lowering the risk of cardiovascular diseases and mortality.
OBJECTIVE
This study aimed to find out metabolic syndrome and life style factors among diabetes patients.
METHODS
A cross-sectional survey was carried out among 296 patients with type 2 diabetes mellitus attending Chitwan Medical College Teaching Hospital. Consecutive sampling technique was used to select sample. Data were collected from 15th December 2021 to 15th March, 2022 using Interview Schedule, bio-physiological measurement and record review. Obtained data were analysed in SPSS version 20 for window using descriptive and inferential statistics. Chi-square test was applied to measure the association between the variables. Logistic regression analysis was performed to identify the factors associated with metabolic syndrome.
RESULT
Findings revealed that the prevalence of MetS was 66.2% and 58.4% in patients according to International Diabetes Federation (IDF) and National Cholesterol Education Program Adult Treatment Panel III (NCEP ATP III) criteria respectively. The most common MetS parameters were raised fasting plasma glucose (94.6%) and abnormal waist circumference (78.4% in IDF criteria) while the least prevalent parameter was reduced HDL level (43.2%). Majorities of the patients were non-vegetarian (85.5%), had poor dietary compliance (poor-46.3%, very poor-32.1%), overweight/obese (65.5%), and suffered from moderate stress (90.1%). Bivariate analysis showed that MetS as per NCEP ATP criteria was significantly associated with gender (p = 0.006), occupation (p = 0.007), presence of other co-morbid condition (<0.001) and sleep problem (p = <0.001). However, MetS as per IDF criteria was significantly associated with age (p = <0.028), duration of diabetes (p = <0.001), follow-up visit (p = <0.030), blood sugar monitoring (p = <0.009) and physical activity of diabetes patients (p = <0.001). Further logistic regression analysis revealed that sleep problem (AOR = 21.812;95%CI = 8.512,55.894) and presence of other comorbidities (AOR = 4.024;95%CI = 2.220,7.295) were the significant factors of metabolic syndrome.
CONCLUSION AND RECOMMENDATION
Metabolic syndrome is high in patients with type 2 diabetes mellitus. Therefore, treating physicians and other health workers need to monitor MetS parameters regularly to reduce the risk of cardiovascular diseases, stroke and premature death.
Identifiants
pubmed: 37228052
doi: 10.1371/journal.pone.0286139
pii: PONE-D-22-28771
pmc: PMC10212170
doi:
Substances chimiques
Adenosine Triphosphate
8L70Q75FXE
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e0286139Informations de copyright
Copyright: © 2023 Sharma et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Déclaration de conflit d'intérêts
The authors have declared that no competing interest exists.
Références
BMC Endocr Disord. 2017 Dec 12;17(1):76
pubmed: 29233152
BMC Cardiovasc Disord. 2018 Jul 17;18(1):149
pubmed: 30016936
Exp Ther Med. 2014 Dec;8(6):1867-1873
pubmed: 25371746
J Diabetes Metab Disord. 2020 May 05;19(1):437-443
pubmed: 32550195
Eur Heart J. 2004 May;25(9):735-41
pubmed: 15120883
BMC Res Notes. 2019 Sep 18;12(1):603
pubmed: 31533851
Curr Hypertens Rep. 2018 Feb 26;20(2):12
pubmed: 29480368
BMC Med. 2011 May 05;9:48
pubmed: 21542944
Eur Heart J. 2010 Mar;31(6):737-46
pubmed: 19933515
Int J Hypertens. 2013;2013:653789
pubmed: 23533715
Front Public Health. 2022 Jan 24;9:811006
pubmed: 35141192
Indian J Med Res. 2010 Feb;131:206-16
pubmed: 20308746
J Assoc Physicians India. 2008 Nov;56:865-8
pubmed: 19263684
Lancet. 2005 Sep 24-30;366(9491):1059-62
pubmed: 16182882
Diabetes Care. 2010 Feb;33(2):378-84
pubmed: 19880581
Diabetes Care. 1993 May;16(5):728-33
pubmed: 8495612
J Pak Med Assoc. 2007 May;57(5):239-42
pubmed: 17571479
Dis Model Mech. 2009 May-Jun;2(5-6):231-7
pubmed: 19407331
J Educ Health Promot. 2021 Jan 28;10:11
pubmed: 33688520
Glob J Health Sci. 2013 Sep 17;5(6):142-55
pubmed: 24171882
J Diabetes Metab Disord. 2014 Nov 23;13(1):104
pubmed: 25469328
PLoS One. 2020 Nov 2;15(11):e0241432
pubmed: 33137150
Diabetes Care. 2017 Jul;40(7):813-820
pubmed: 28637886
Ethiop J Health Sci. 2018 Sep;28(5):645-654
pubmed: 30607080
BMC Cardiovasc Disord. 2022 Aug 10;22(1):366
pubmed: 35948874
World J Diabetes. 2016 Jun 25;7(12):243-51
pubmed: 27350847
Atherosclerosis. 2007 Nov;195(1):189-94
pubmed: 17064711
Iran J Med Sci. 2015 Nov;40(6):522-5
pubmed: 26538781
J Diabetes Metab Disord. 2014 Jul 15;13:80
pubmed: 25054102
Int J Appl Basic Med Res. 2015 May-Aug;5(2):133-8
pubmed: 26097823